NEOGENOMICS INC
NEO · XNASCIK 1077183fmd_0DF34GD8576HVWXQJ92EDM49H9Services · Services-Testing LaboratoriesTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2026, 66 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 232 | 240 | 277 | 409 | 444 | 484 | 510 | 592 | 661 | 727 |
| Cost of revenue | 134 | 138 | 149 | 212 | 259 | 297 | 322 | 347 | 370 | 413 |
| Net interest income | 10 | 6 | – | – | – | – | – | – | – | – |
| Gross profit | 98 | 102 | 127 | 197 | 186 | 187 | 188 | 245 | 290 | 314 |
| Research and development | 5 | 4 | 3 | 8 | 8 | 22 | 30 | 27 | 31 | 37 |
| Selling, general and administrative | 88 | 94 | 114 | 175 | 192 | 284 | 311 | 314 | 344 | 365 |
| Total operating expenses | 96 | 99 | 117 | 184 | 200 | 306 | 346 | 352 | 382 | 430 |
| Operating income | 2 | 3 | 10 | 13 | (14) | (119) | (158) | (108) | (92) | (116) |
| Interest expense | 10 | 6 | 6 | 4 | 7 | 8 | 8 | 7 | 7 | 4 |
| Interest and investment income | – | – | – | – | – | – | 6 | 17 | 18 | 9 |
| Other non-operating income (expense) | 0 | (0) | 0 | (5) | 8 | (0) | (0) | 1 | (0) | 0 |
| Income before taxes | (8) | (3) | 4 | 4 | (14) | (15) | (159) | (97) | (81) | (110) |
| Income tax expense | (2) | (2) | 1 | (4) | (18) | (7) | (15) | (9) | (2) | (2) |
| Net income from continuing operations | (6) | (0) | 3 | 8 | 4 | (8) | (144) | (88) | (79) | (108) |
| Net income | (6) | (0) | 3 | 8 | 4 | (8) | (144) | (88) | (79) | (108) |
| Net income to common shareholders | (31) | (11) | 6 | 8 | 4 | (8) | (144) | (88) | (79) | – |